EX-10.23
from S-1/A
6 pages
Transaction: Loan Borrower: Sunesis Pharmaceuticals, Inc. Lender: General Electric Capital Corporation, Its Affiliates or Its Assignee (“Ge Capital”) Loan Amount: $2,500,000 Equipment: Laboratory and Scientific Equipment, Computer Equipment, FF&E, and Soft Cost as Detailed in the Attached Addendum A. Equipment Acquired 3/1/05 and After May Be Included in the Line. All Equipment Is to Be Acceptable to Ge Capital and Will Be Free and Clear of Other Liens, Claims, and Encumbrances. Loan Term and Payment: Computer Equipment and Soft Cost: 36 Months of Principal and Interest @ 3.16067% of Financed Cost, Paid Monthly in Advance for Each Loan Schedule, Full Payout. (9.10% All-In Rate). All Other Equipment: 48 Months of Principal and Interest @ 2.47675% of Financed Cost, Paid Monthly in Advance for Each Loan Schedule, Full Payout. (9.15% All-In Rate). Anticipated Funding Period: Through 12/31/06. Line Mechanics: Minimum Fundings Will Be $75,000, With No More Than One Funding Per Month. for Schedules Subsequent to the First, Equipment With Invoice Dates Older Than 90 Days Will Be Financed at Appropriate Discount. Amortization Begins on the First of the Month Start Date. Interim Interest Will Be Charged for Any Period Between the Funding Date and the Start Date. Warrants: The Company Paid a Warrant (Dated 6/21/04, 1,435 Shares of Series C-1 Pf. Stock) for an Additional $302,850 Soft Cost on the Prior Line. the Additional Soft Cost Was Never Used. Therefore, the Warrant Will Be Carried Over to Cover the First
12/34/56
